← Back to Clinical Trials
Recruiting NCT07620210

NCT07620210 Effects of CTAR and a Swallowing Pressure Ball in Older Stroke Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07620210
Status Recruiting
Phase
Sponsor Chimei Medical Center
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 132 participants
Start Date 2026-03-18
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 90 Years
Study Type INTERVENTIONAL
Interventions
Innovative Swallowing Pressure Measurement Ball Combined With CTAR TrainingConventional Swallowing Rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 132 participants in total. It began in 2026-03-18 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effectiveness of resistance swallowing rehabilitation using Chin Tuck Against Resistance (CTAR) exercises combined with an innovative swallowing pressure ball in improving swallowing function and swallowing-related quality of life among home-based older stroke patients with dysphagia. Participants will receive a 12-week swallowing rehabilitation program conducted in the home-care setting. Outcome measures include swallowing function assessments, swallowing-related quality of life, and rehabilitation adherence. The study is designed as a randomized controlled trial to explore the feasibility and clinical benefits of resistance-based swallowing rehabilitation in community and home-care environments.

Eligibility Criteria

Inclusion Criteria: * Age between 65 and 90 years. * Diagnosed with ischemic or hemorrhagic stroke more than 6 months prior to enrollment. * Receiving home care services from participating home care agencies. * Able to follow instructions and participate in swallowing training. * MMSE score ≥24, or adjusted according to education level. * Passed the second stage of the 3-step swallowing screening test. * Presence of post-stroke dysphagia symptoms. Exclusion Criteria: * History of head and neck cancer or head and neck radiotherapy. * History of cervical spine surgery or tracheostomy. * Severe neurological or neuromuscular diseases affecting swallowing function. * Severe unstable medical conditions. * Current use of medications significantly affecting swallowing function or muscle tone. * Unable to complete the intervention or follow-up assessments. * Receiving tube feeding without oral intake ability.

Contact & Investigator

Central Contact

nai ching Chen, RN

✉ dreampatty11@gmail.com

📞 +886 988031533

Frequently Asked Questions

Who can join the NCT07620210 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07620210 currently recruiting?

Yes, NCT07620210 is actively recruiting participants. Contact the research team at dreampatty11@gmail.com for enrollment information.

Where is the NCT07620210 trial being conducted?

This trial is being conducted at Tainan, Taiwan.

Who is sponsoring the NCT07620210 clinical trial?

NCT07620210 is sponsored by Chimei Medical Center. The trial plans to enroll 132 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology